Submit your email address to sign up for the Visionary,
or monthly newsletter.

X

Search the Radiation Oncology Institute

X

Submit your email address to sign up for the Visionary,
or monthly newsletter.

X

Search the Radiation Oncology Institute

X
Close Index

The Visionary (Fall 2022, Vol. 12, No. 3)

2022 Publication Award Honors Research on the Quality of Peer Review During COVID-19
Ryan T. Hughes, MD, is being recognized for his timely and insightful study on the impact of holding in-person vs. virtual peer review conferences.
Apply Now for “A New Era of Radiotherapy” Funding Opportunity
ROI is accepting Letters of Intent for research proposals on new radiotherapy methods through November 10 at 5:00 p.m. Eastern time.
Register for the ROI 5K
Join ROI and your fellow ASTRO Annual Meeting attendees in San Antonio on Tuesday, October 25 at 7:00 a.m. Central time to run or walk for research!
Share Your Thoughts on the ROI’s Research Priorities
ROI is updating its Research Agenda and seeking feedback from the radiation oncology community. Help shape the ROI’s priorities by participating in the research needs assessment survey today.
ROI Research Results and More at the ASTRO Annual Meeting
Make plans to visit the ROI booth in the Main Lobby and find out when and where you can see the 12 abstracts being presented by ROI-funded teams.
Issue Index

ROI Research Results and More at the ASTRO Annual Meeting

ROI-funded researchers are presenting twelve abstracts at the ASTRO Annual Meeting in San Antonio. This record number of abstracts at a single meeting is a testament to the growing success of the ROI’s research program, which was launched just over a decade ago. The abstracts cover a range of disease sites and a wide variety of topics from artificial intelligence to workforce diversity. A schedule of the abstracts is included below, and all Annual Meeting attendees are encouraged to go see the presentations to hear about the results of the innovative studies that ROI researchers are conducting.
 
Annual Meeting attendees are invited to stop by the ROI booth in the Main Lobby of the Henry B. Gonzalez Convention Center to talk with ROI leaders and staff. Visitors can watch videos of recent award winners and pick up copies of materials like the current “A New Era of RT” request for proposals (RFP) and the just released “Communicating the External Beam Radiotherapy Experience (CEBRE)” discussion guides for central nervous system, gastrointestinal, and head and neck cancers.
 
On Sunday, October 23 at 4:00 p.m. Central time, ROI is hosting an information session about the “New Era of RT” RFP for residents attending the Annual Meeting. Leaders of the ROI Research Committee and grantees who won ROI awards as residents will be on hand to talk with those interested in applying for the research funding opportunity.
 
Make time to visit the booth to learn more about ROI. See you in San Antonio!

Schedule of ROI Research Results

Sunday, October 23

4:45 p.m.   Poster Q&A 01 – Lung Cancer and DEIH, Exhibit Hall 1

2310: Assessing the Impact of Diverse Approaches of Promoting Virtual Radiation Oncology Educational Content to Medical Students (PI: Malcolm Mattes, MD)
2311: Impact of a Virtual Introduction to Radiation Oncology Lecture on Stimulating Specialty Interest among Diverse Medical Students at Multiple Institutions (PI: Malcolm Mattes, MD)
2312: Pilot Study Exploring the Feasibility and Value of Introducing Diverse Students in Premedical Programs to Multidisciplinary Oncology (PI: Malcolm Mattes, MD)

4:45 p.m.   Scientific Session 05 – Novel Approaches to Palliative Supportive Care: Improving Toxicity, Efficacy, and Equity, Room 007 A/B

126: Natural Language Processing of Symptoms Preceding Diagnosis and Palliative Radiotherapy for Bone Metastases (PI: Julian Hong, MD, MS) 

Monday, October 24

8:00 a.m.   Scientific Session 06 – Exploring Multiple and Evolving Trajectories of AI into Health Care, Room 007 C/D

129: Social Media Sentiments and Treatment Choices for Breast Cancer (PI: Julian Hong, MD, MS)
132: Machine Learning-Based Prediction of Hospitalization Using Daily Step Counts for Patients Undergoing Chemoradiation (PI: Julian Hong, MD, MS, and Nitin Ohri, MD, MS)

8:00 a.m.   Scientific Session 07 – Genomics and Molecular Biomarkers, Room 008

137: Genomic Determinants of Response to Trimodality Therapy for Muscle-Invasive Bladder Cancer (PI: David Miyamoto, MD, PhD)

5:00 p.m.   Poster Q&A 04 – Biology and PRO, Exhibit Hall 1

3008: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer (PaRTNer): Longitudinal Assessment of Financial Toxicity and an Educational Intervention from a Pilot Study (PI: Fumiko Chino, MD, and Yvonne Mowery, MD, PhD)
3021: Prospective Pilot Study to Measure Baseline Anxiety Prior to Radiotherapy after Standard Education at Consultation (PI: Daniel Golden, MD, MHPE)

Tuesday, October 25

4:00 p.m.   Poster Q&A 07 – Hematologic Malignancies and Digital Health Innovation, Exhibit Hall 1

2281: Leveraging Serial MRI Radiomics and Machine Learning to Predict Risk of Radiation Necrosis in Patients with Brain Metastases Managed with Stereotactic Radiation and Immunotherapy (PI: Hesham Elhalawani, MD, MS)

4:00 p.m.   Scientific Session 24 – Advancing Health Equity Along the Cancer Care Continuum, Room 206

229: Development of gRADient: An Inclusive Tool for Objective Measurement of Radiation Acute Skin Toxicity Across Skin Tones in Breast Cancer (PI: Sara Alcorn, MD, PhD, MPH, and Crystal Aguh, MD)
230: A Comprehensive Overview of Academic Radiation Oncology Departmental Efforts in Diversity, Equity, and Inclusion (PI: Malcolm Mattes, MD)